$BPMX BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea BPMX https://www.otcmarkets.com/stock/BPMX/news/story?e&id=1383668 https://investorshub.advfn.com/uimage/uploads/2019/6/26/oezgcBPMX.png